Back to Market Feed

Historical record - last NADAC effective date: 1/22/2014

Product Information

AMPICILLIN-SULBACTAM 15 GM VL is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $24.6333 per EA under NDC 00641611801. Its NADAC has been published 5 times since Jan 22, 2014.

FDA first approved this application on Dec 23, 2009. Its Orange Book therapeutic-equivalence code is AP.

AMPICILLIN-SULBACTAM 15 GM VL

Ampicillin and Sulbactam
$24.6333per EA

Strength

100; 50 mg/mL; mg/mL

NDC

00641611801

Classification

Generic

Dosage Form

INJECTION, POWDER, FOR SOLUTION

Route

INTRAVENOUS

Effective Date

1/22/2014

Approval Type

Generic (ANDA)

FDA Application

ANDA065403

FDA Approved

12/23/2009

TE Code

AP

On Market Since

12/3/2009

Pharmacological Classes

Penicillin-class Antibacterial
Penicillins
beta Lactamase Inhibitor
beta Lactamase Inhibitors

Price Statistics

The NADAC for AMPICILLIN-SULBACTAM 15 GM VL has been published 5 times since Jan 22, 2014, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$24.6333 per EA
All-time high$24.6333 (Feb 19, 2014)
All-time low$24.6333 (Jan 22, 2014)
Median price$24.6333
Average price$24.6333
Largest weekly change0.0% (Jan 29, 2014)
Weeks tracked5
Tracking sinceJan 22, 2014

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

0.0%

Last surveyed Feb 19, 2014 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Ampicillin and Sulbactam market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

AMOXICILLIN 125 MG/5 ML SUSP
Generic
00143988815•Hikma Pharmaceuticals USA Inc.
$0.0185
per ML
AMOXICILLIN 125 MG/5 ML SUSP
Generic
00781603955•Sandoz Inc.
$0.0185
per ML
AMOXICILLIN 125 MG/5 ML SUSP
Generic
65862070655•Aurobindo Pharma Limited
$0.0185
per ML
AMOXICILLIN 125 MG/5 ML SUSP
Generic
00143988801•Hikma Pharmaceuticals USA Inc.
$0.0211
per ML
AMOXICILLIN 125 MG/5 ML SUSP
Generic
00781603946•Sandoz Inc.
$0.0211
per ML
AMOXICILLIN 125 MG/5 ML SUSP
Generic
65862070601•Aurobindo Pharma Limited
$0.0211
per ML
AMOXICILLIN 125 MG/5 ML SUSP
Generic
00143988880•Hikma Pharmaceuticals USA Inc.
$0.0231
per ML
AMOXICILLIN 125 MG/5 ML SUSP
Generic
00781603958•Sandoz Inc.
$0.0231
per ML
AMOXICILLIN 125 MG/5 ML SUSP
Generic
65862070680•Aurobindo Pharma Limited
$0.0231
per ML
AMOXICILLIN 250 MG/5 ML SUSP
Generic
00093415573•Teva Pharmaceuticals USA Inc.
$0.0242
per ML

Frequently asked questions

What is the NADAC price of AMPICILLIN-SULBACTAM 15 GM VL?

The current National Average Drug Acquisition Cost (NADAC) for AMPICILLIN-SULBACTAM 15 GM VL, manufactured by Hikma Pharmaceuticals USA Inc., is $24.6333 per EA (NDC 00641611801), effective Feb 19, 2014.

How has the price of AMPICILLIN-SULBACTAM 15 GM VL changed over time?

Over the history we have for it, the NADAC for AMPICILLIN-SULBACTAM 15 GM VL has held within roughly two percent of its current level. It has been tracked across 5 weekly CMS publications since Jan 22, 2014.

What are the highest and lowest recorded NADAC prices for AMPICILLIN-SULBACTAM 15 GM VL?

Since Jan 22, 2014, the NADAC for AMPICILLIN-SULBACTAM 15 GM VL has ranged from a low of $24.6333 (Jan 22, 2014) to a high of $24.6333 (Feb 19, 2014), with a median of $24.6333 per EA.

Are there cheaper alternatives to AMPICILLIN-SULBACTAM 15 GM VL?

No other NADAC-published product currently shares the active ingredient and strength of AMPICILLIN-SULBACTAM 15 GM VL in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures AMPICILLIN-SULBACTAM 15 GM VL?

AMPICILLIN-SULBACTAM 15 GM VL (NDC 00641611801) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.